Dana Brown

1 month ago | auntminnie.com | Amerigo Allegretto |Liz Carey |Erik Anderson |Dana Brown

AI software developer iCAD and PACS vendor RamSoft have entered a preferred distributor and integration partnership. Under the agreement, RamSoft will integrate iCAD's ProFound AI Breast Health Suite in its PowerServer RIS/PACS software, which is used by more than 750 imaging centers worldwide, the companies said. iCAD’s technology is based on data from a woman's 2D digital screening mammogram and is designed to help detect cancers in between screening intervals, according to the company.

1 month ago | auntminnie.com | Amerigo Allegretto |Liz Carey |Erik Anderson |Dana Brown

Lunit subsidiary Volpara Health's volumetric breast density assessment has been integrated into the newly released version of the BOADICEA (also known as CanRisk) breast cancer risk model. Studies have shown the use of Volpara density in BOADICEA to improve model accuracy compared with using BI-RADS density categories, the company said. Volpara also reported that it has inked an agreement with Optellum, an AI lung cancer diagnosis developer.

1 month ago | auntminnie.com | Amerigo Allegretto |Liz Carey |Erik Anderson |Dana Brown

Outpatient medical imaging provider SimonMed Imaging has implemented MagView's Luminary Risk risk assessment software into its Personalized Breast Cancer Detection program. Luminary Risk helps users identify women who may need additional screening beyond a standard mammogram, and consists of a patient history collection platform that highlights actionable risk scores, patient recommendations, and care plans, SimonMed said.

2 months ago | auntminnie.com | Liz Carey |Erik Anderson |Dana Brown |Amerigo Allegretto

Susan G. Komen urged quick passage of legislation introduced in Pennsylvania to eliminate out-of-pocket costs for women for necessary diagnostic breast cancer imaging. “Nobody should be forced to skip medical care that helps to detect breast cancer early because of the cost, yet thousands of Pennsylvanians are forced to make that decision every year,” noted Molly Guthrie, vice president of policy and advocacy at Susan G. Komen, in a news release. HB 433 was introduced by Rep.

Jan 22, 2025 | auntminnie.com | Liz Carey |Erik Anderson |Dana Brown |Amerigo Allegretto

Hologic has received a warning letter from the U.S. Food and Drug Administration (FDA) for not addressing violations related to the company’s BioZorb 3D bioabsorbable radiographic markers. The letter follows a previous warning by the FDA to consumers, healthcare providers, and healthcare facilities not to use the markers as well as a voluntary recall by Hologic, both issued in October. To date, 252 injuries related to the markers have been reported.